Molecular analysis of the function of BRCA1-TONSL complexes

BRCA1-TONSL 复合物功能的分子分析

基本信息

  • 批准号:
    8549706
  • 负责人:
  • 金额:
    $ 4.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-04-01 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): BRCA1 (B1) is a breast and ovarian tumor suppressor. Its best known function is in the repair of double strand breaks (DSB) by homologous recombination (HR). It can also function in other types of DNA damage repair (cf below), as well as in DNA damage checkpoints. However, there is limited in depth knowledge about any of the purported functions for B1or how it acts as a tumor suppressor. To address this problem, we purified B1-containing protein complexes from a human cell line and analyzed the complexes by mass spectrometry (MS). Our hope was that by better defining the B1 protein partner repertoire we might be able to better understand known B1 functions or potentially hypothesize new B1 functions based on the known functions of identified interactors. In this analysis, we repeatedly identified a protein called TONSL (aka NFKBIL2) as a B1 interactor. This protein has been suggested to function in the repair of collapsed replication forks. Recently, our group has shown that B1 functions in the repair of stalled replication forks. Given the similar suggested function for both proteins, and based on our preliminary analysis of the B1-TONSL interaction, we hypothesize that B1 recruits TONSL to collapsed replication forks to aid in the repair of DSB breaks arising at these sites. The four specific aims of this proposal wil focus on this hypothesis. The goal of specific aim 1 will be to perform a structure function analysis on the B1-TONSL interaction as a means of assessing, genetically, the hypothesis that B1 recruits TONSL to collapsed forks and that the B1- TONSL complex is involved in repair of these structures. The goal of aim 2 will be to understand an observation from our preliminary data. We find that after UV damage, B1 localizes at UV damage sites in virtually all S/G2 cells. However, TONSL co-localizes with B1 at these sites in only some of these cells. The goal of aim 2 is to determine why this is the case, which could shed light on how B1-TONSL complexes function. The goal of aim 3 is to search for and, if feasible, identify other members of the B1-TONSL subcomplex, by affinity purification and MS. By doing this we hope to identify subunits with known biochemical functions and then assess the contributions of these properties to B1-TONSL function and vice versa. This approach could further illuminate aspects of the function of this complex at collapsed forks and/or suggest new hypotheses for the function of this complex. The goal of aim 4 is to determine, with help from collaborators, whether TONSL and/or any other member of the B1-TONSL complex is a product of a breast cancer suppressor gene by searching for relevant mutations in whole genome sequence libraries of breast tumors. This work will be supervised by the candidate's sponsor in a program composed of laboratory-based research training leavened by attendance at relevant scientific meetings. Ideally, success in this effort will contribute to a better understanding of B1 function and how loss of B1 function leads to breast and/or ovarian cancer.
DESCRIPTION (provided by applicant): BRCA1 (B1) is a breast and ovarian tumor suppressor. Its best known function is in the repair of double strand breaks (DSB) by homologous recombination (HR). It can also function in other types of DNA damage repair (cf below), as well as in DNA damage checkpoints. However, there is limited in depth knowledge about any of the purported functions for B1or how it acts as a tumor suppressor. To address this problem, we purified B1-containing protein complexes from a human cell line and analyzed the complexes by mass spectrometry (MS). Our hope was that by better defining the B1 protein partner repertoire we might be able to better understand known B1 functions or potentially hypothesize new B1 functions based on the known functions of identified interactors. In this analysis, we repeatedly identified a protein called TONSL (aka NFKBIL2) as a B1 interactor. This protein has been suggested to function in the repair of collapsed replication forks. Recently, our group has shown that B1 functions in the repair of stalled replication forks. Given the similar suggested function for both proteins, and based on our preliminary analysis of the B1-TONSL interaction, we hypothesize that B1 recruits TONSL to collapsed replication forks to aid in the repair of DSB breaks arising at these sites. The four specific aims of this proposal wil focus on this hypothesis. The goal of specific aim 1 will be to perform a structure function analysis on the B1-TONSL interaction as a means of assessing, genetically, the hypothesis that B1 recruits TONSL to collapsed forks and that the B1- TONSL complex is involved in repair of these structures. The goal of aim 2 will be to understand an observation from our preliminary data. We find that after UV damage, B1 localizes at UV damage sites in virtually all S/G2 cells. However, TONSL co-localizes with B1 at these sites in only some of these cells. The goal of aim 2 is to determine why this is the case, which could shed light on how B1-TONSL complexes function. The goal of aim 3 is to search for and, if feasible, identify other members of the B1-TONSL subcomplex, by affinity purification and MS. By doing this we hope to identify subunits with known biochemical functions and then assess the contributions of these properties to B1-TONSL function and vice versa. This approach could further illuminate aspects of the function of this complex at collapsed forks and/or suggest new hypotheses for the function of this complex. The goal of aim 4 is to determine, with help from collaborators, whether TONSL and/or any other member of the B1-TONSL complex is a product of a breast cancer suppressor gene by searching for relevant mutations in whole genome sequence libraries of breast tumors. This work will be supervised by the candidate's sponsor in a program composed of laboratory-based research training leavened by attendance at relevant scientific meetings. Ideally, success in this effort will contribute to a better understanding of B1 function and how loss of B1 function leads to breast and/or ovarian cancer.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sarah James Hill其他文献

Sarah James Hill的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sarah James Hill', 18)}}的其他基金

Dissecting the interaction between DNA damage repair defects and the tumor microenvironment
剖析DNA损伤修复缺陷与肿瘤微环境之间的相互作用
  • 批准号:
    10260641
  • 财政年份:
    2020
  • 资助金额:
    $ 4.49万
  • 项目类别:
Dissecting the interaction between DNA damage repair defects and the tumor microenvironment
剖析DNA损伤修复缺陷与肿瘤微环境之间的相互作用
  • 批准号:
    10477023
  • 财政年份:
    2020
  • 资助金额:
    $ 4.49万
  • 项目类别:
Dissecting the interaction between DNA damage repair defects and the tumor microenvironment
剖析DNA损伤修复缺陷与肿瘤微环境之间的相互作用
  • 批准号:
    10693143
  • 财政年份:
    2020
  • 资助金额:
    $ 4.49万
  • 项目类别:
Dissecting the interaction between DNA damage repair defects and the tumor microenvironment
剖析DNA损伤修复缺陷与肿瘤微环境之间的相互作用
  • 批准号:
    10018165
  • 财政年份:
    2020
  • 资助金额:
    $ 4.49万
  • 项目类别:
Targeting molecular vulnerabilities of ovarian cancer
针对卵巢癌的分子脆弱性
  • 批准号:
    9976800
  • 财政年份:
    2020
  • 资助金额:
    $ 4.49万
  • 项目类别:
Molecular analysis of the function of BRCA1-TONSL complexes
BRCA1-TONSL 复合物功能的分子分析
  • 批准号:
    8312251
  • 财政年份:
    2012
  • 资助金额:
    $ 4.49万
  • 项目类别:
Molecular analysis of the function of BRCA1-TONSL complexes
BRCA1-TONSL 复合物功能的分子分析
  • 批准号:
    8830934
  • 财政年份:
    2012
  • 资助金额:
    $ 4.49万
  • 项目类别:
Molecular analysis of the function of BRCA1-TONSL complexes
BRCA1-TONSL 复合物功能的分子分析
  • 批准号:
    8629543
  • 财政年份:
    2012
  • 资助金额:
    $ 4.49万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 4.49万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.49万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 4.49万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.49万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 4.49万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 4.49万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.49万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 4.49万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 4.49万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.49万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了